Improved T Cell Immunity Following Neoadjuvant Chemotherapy in Ovarian Cancer

Comprehensive Integration of Single-Cell Data

Tim Stuart, Andrew Butler, Paul J. Hoffman, et al.. (2018). Cell. Cited 11,858 times. https://doi.org/10.1101/460147

Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

D. Keskin, Annabelle J Anandappa, Jing Sun, et al.. (2018). Nature. Cited 1,140 times. https://doi.org/10.1038/s41586-018-0792-9

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

L. Galluzzi, I. Vitale, S. Warren, et al.. (2020). Journal for Immunotherapy of Cancer. Cited 825 times. https://doi.org/10.1136/jitc-2019-000337

Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer

E. Parkes, S. Walker, Laura Taggart, et al.. (2016). JNCI Journal of the National Cancer Institute. Cited 413 times. https://doi.org/10.1093/jnci/djw199

Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma

Zhuting Hu, Donna E. Leet, R. Allesøe, et al.. (2021). Nature Medicine. Cited 412 times. https://doi.org/10.1038/s41591-020-01206-4

A single-cell landscape of high-grade serous ovarian cancer

B. Izar, I. Tirosh, E. Stover, et al.. (2020). Nature Medicine. Cited 371 times. https://doi.org/10.1038/s41591-020-0926-0

Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity.

V. Almendro, Yu-Kang Cheng, A. Randles, et al.. (2014). Cell reports. Cited 259 times. https://doi.org/10.1016/j.celrep.2013.12.041